Detailed Notes on Psychiatry Terms and Concepts

NEUROBIOLOGY AND GENETICS OF MENTAL DISORDERS

  • Key anatomical systems: Prefrontal, limbic, and basal ganglia systems.
  • Functional systems: Executive functioning, memory, language, attention, and reward processing.
  • The brain operates through continuous analysis and synthesis, establishing plastic synapses (neuroplasticity).
  • Neuroimaging studies have enhanced our understanding of the CNS.

PREFRONTAL CORTEX AND EXECUTIVE FUNCTIONS

  • Comprises 29% of the cortex in humans; significant for integrating signals from various brain regions.
  • Executive functions include:
    • High-order abstract thinking
    • Creative problem-solving
    • Temporal sequencing of behavior
    • Attention and perception
    • Moral judgement, emotional integration, and affectivity
  • Measured through standard neuropsychological tests: Wisconsin Card Sorting Test, Continuous Performance Test, Sternberg Working Memory Task, Tower of London.
  • Frontal lobe abnormalities associated with schizophrenia, mood disorders, OCD, and autism spectrum disorders.

LIMBIC SYSTEM

  • Circular structure surrounding the occipital, parietal, and prefrontal areas of the brain.
  • Connects to the reptilian brain and is vital for regulating the CNS.
  • Functions include:
    • Integrating visceral sensations with external environmental experiences
    • Long-term learning and memory
    • Attention, cognition, emotions, instincts, personality, and behavior.
  • Involves critical structures such as the hypothalamus, amygdala, and hippocampus, sharing interconnections that regulate emotions and behavior.
  • The amygdala plays a key role in anxiety disorders.

BASAL GANGLIA

  • Composed of key structures: caudate nucleus, putamen, globus pallidus, and amygdala.
  • High concentration of dopamine D2 receptors, important sites for antipsychotic drug action.
  • Huntington’s disease leads to severe atrophy of the caudate nucleus, resulting in delusional and depressive symptoms, with potential dementia.
  • Parkinson’s disease affects the basal ganglia through neuronal loss in the substantia nigra, showcasing schizophrenia-like symptoms, emotional blunting, and loss of volition.

MEMORY SYSTEM

  • Learning and memory deficits are hallmark features of dementias.
  • Neurosis such as anxiety disorders or hysteria may stem from painful repressed memories that are psychologically unintegrated.
  • Long-term memory relies on protein synthesis in connected neurons as short-term learning occurs, facilitating molecular consolidation of memories.
  • Two stages of memory:
    1. Functional (working) memory: Accessible in short-term storage, akin to mental notes during calculations.
    2. Long-term (consolidated) memory: Information retained for extensive periods.

LANGUAGE SYSTEM

  • Language systems are predominantly located in the left neocortex:
    • Broca's area (speech production): Involves syntax structure; injury leads to speech disruptions (stuttering or grammatical errors).
    • Wernicke's area (auditory association cortex): Encodes language comprehension; damage results in disorganized speech and comprehension loss.
    • Auditory hallucinations and neologisms are notable language disorders in schizophrenia.

ATTENTION SYSTEM

  • Attention is a cognitive process through which relevant stimuli are identified within time and context.
  • Vital brain regions: reticular activating system, which initiates alerts to the brain via pathways broadcasting through the thalamus.
  • Attention deficits are common in schizophrenia, ADHD, and mood disorders.

REWARD SYSTEM

  • Constructs the neural pathways for pleasure and motivation, facilitated by dopamine.
  • Disruptions connect to addictive behaviors, leading to implications for substance abuse and eating disorders.
  • Includes key components: ventral tegmental area, nucleus accumbens, and prefrontal cortex.

NEUROCHEMICAL SYSTEMS

  • Neurochemical systems supply the necessary "fuel" for functional and anatomical systems to operate.
  • Monoamine hypothesis: Depression linked to deficient neurotransmitters (noradrenaline, dopamine, serotonin).

DOPAMINE SYSTEM

  • Dopamine governs cognition and emotion as the reward neurotransmitter and modulates addiction pathways.
  • Three sub-systems using dopamine as the primary transmitter:
    • Nigrostriatal pathway (motor control): Loss relates to Parkinson's.
    • Mesolimbic/microcortical pathway (reward learning): Changes in this system disturb emotional regulation in schizophrenia.
    • Tuberoinfundibular system: Modulates hormone secretion, including prolactin release.

NOADRENALINE SYSTEM

  • Originates from the locus coeruleus and produces widespread effects across CNS, mediating major mood disorders.
  • Its activity influences symptoms in multiple mental diseases, underlining the potential of noradrenergic antidepressants.

SEROTONIN SYSTEM

  • Neural pathways involved in mood, anxiety, and aggressive behavior, originating from the brainstem's raphe nuclei.
  • High serotonin levels correlate with life satisfaction; deficiencies are implicated in depression and potentially psychosis.

CHOLINERGIC SYSTEM

  • Linked to learning and memory processes, particularly in dementia, correlating with acetylcholine levels and cognitive decline.

GABA SYSTEM

  • GABA acts as the main inhibitory neurotransmitter; deficiency or dysfunction leads to anxiety disorders.
  • Activities involve benzodiazepine medications to enhance GABAergic transmission and restore balance.

GLUTAMATE SYSTEM

  • Key neurotransmitter for synaptic plasticity, its dysregulation associated with schizophrenia, depression, and bipolar disorder.
  • Neurotoxicity at elevated levels correlates with cognitive deficits and neurotoxicity in stress conditions.

GENETICS OF MENTAL DISORDERS

  • Genetics play a crucial role in mental health disorders; forward-looking familial studies indicate hereditary patterns related to diverse mental conditions (depression, bipolar disorder, schizophrenia).
  • Heritability studies (twin/adoption) illustrate genetic contributions, underscoring the complexity of gene-environment interactions.
  • Searching for Genes:
    • Linkage studies and studies of candidate genes reveal specific chromosomal associations with syndromes (e.g., schizophrenia linked to chromosomes 6, 8, and 22, bipolar disorder linked to chromosomes 11 and X).

DISRUPTIVE BEHAVIOR DISORDERS

  • Notable impairments in self-regulation, causing interpersonal conflicts.
  • Oppositional Defiant Disorder:
    • Persistent argumentative/defiant behavior, frequency of attitudes leads to conflict.
    • Prevalence approximately 3%; significant risks of developing conduct disorders.
  • Conduct Disorder:
    • Patterns exhibit aggression and violation of rules, marking a precursory route to antisocial personality in adulthood.
    • Treatment emphasizes non-pharmacological interventions focusing on cognitive and family engagement.

ANXIETY DISORDERS

  • High prevalence across populations; fundamental fear disproportionate to situations.
  • Comprising various types like Separation Anxiety, Selective Mutism, and Specific Phobias, which share common characteristics yet diverge in treatment pathways and implications for social functioning.

OBSESSIVE-COMPULSIVE DISORDER

  • Characterized by obsessive thoughts and compulsive behaviors aimed at reducing distress; operationally significant impairments arise over time.
  • Treatments include exposure and response prevention coupled with cognitive restructuring interventions.

TRAUMA AND STRESS-RELATED DISORDERS

  • Framework involving mental health impacts from exposure to trauma (e.g., PTSD).
  • Reactive Attachment Disorder: Commonly results from neglect/abuse in childhood, leading to maladaptive relational behaviors.

SLEEP DISORDERS

  • Sleep disturbances (e.g., insomnia, hypersomnia) significantly impair daily function.
  • Sleep examination (like polysomnography) helps diagnose various disorders such as Narcolepsy and Sleep Apnea, often requiring behavioral and pharmacological management strategies.

MOOD DISORDERS

  • High incidences leading to personal dysfunction, notably major depressive disorder and bipolar disorder—critical areas for evaluation regarding symptomatic presentations (e.g., mood fluctuations, depressive episodes).
  • Management often involves both pharmacological interventions (antidepressants, mood stabilizers) as well as psychotherapeutic techniques, notably Cognitive Behavioral Therapy.

PSYCHOPHARMACOLOGY AND ECT

  • Psychopharmacological interventions vital for alleviating psychotic symptoms (e.g., from schizophrenia), utilizing antipsychotics for both acute and chronic management.
  • Electroconvulsive therapy (ECT) remains a consensus adjunct for treatment-resistant mood disorders—offering rapid results under precise clinical conditions.

LEGAL CONSIDERATIONS

  • Informed Consent: Essential for ethical psychiatric practice, detailing thorough comprehension pre-treatment; must account for capacity and mental status in line with legal statutes.
  • Involuntary Treatment: Legal parameters allow for urgent intervention in cases where individuals pose risks to themselves or others; balancing ethicality against legal responsibilities remains a consistent theme.

FORENSIC PSYCHIATRY

  • Focus on the intersection between psychiatric evaluations and legal accountability:
    • Competency to stand trial, determinant culpability, etc.—navigating nuanced legal frameworks necessitating comprehensive understanding of both mental health and legal theory.

This summary extracts key insights from the PDF transcripts on psychiatric topics covered, serving as a comprehensive study aid.